Mary Nyberg
Corporate Officer/Principal bei PROCESSA PHARMACEUTICALS, INC.
Profil
Mary Nyberg is currently the Vice President-Clinical Operations at Processa Pharmaceuticals, Inc. She previously worked as the Director-Clinical Operations at Questcor Pharmaceuticals, Inc. and as the Associate Director-Clinical Project Management at Quintiles, Inc. (California).
Ms. Nyberg completed her undergraduate degree at Montclair State University and holds an MBA from the University of Phoenix.
Aktive Positionen von Mary Nyberg
| Unternehmen | Position | Beginn |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mary Nyberg
| Unternehmen | Position | Ende |
|---|---|---|
| QUESTCOR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Mary Nyberg
| Montclair State University | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
